Correlation of Rapid Point-of-Care vs Send-Out Fecal Calprotectin Monitoring in Pediatric Inflammatory Bowel Disease

BÜHLMANN Quantum Blue® fCAL extended Citation:

Rodriguez, A. et al.  Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease. World J Gastrointest Pharmacol Ther 8(2):127-130. Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.127.

Highlight from this Publication

“In summary, we present the first correlation study of rapid POC calprotectin testing in a pediatric IBD cohort in the United States. Unlike the conventional send-out ELISA which typically takes 10-14 d to result, the future clinical use of POC calprotectin could improve the utility in the decision-making process if levels were available at or near the time of actual care.”

Quantum Blue® fCAL extended is for Research Use Only. Not for use in diagnostic procedures in the US.
Quantum Blue® fCAL extended: Health Canada Licence: 100161